Appointed
Bethany H. Corum
Director of Capital City Bank
CCBG ·
CAPITAL CITY BANK GROUP INC
elected Mrs. Corum as a member of the Board of Directors of the Bank
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5101–5150 of 76325
Role change
William G. Smith, Jr.
President of CCBG and Chairman of Capital City Bank
CCBG ·
CAPITAL CITY BANK GROUP INC
William G. Smith, Jr. notified CCBG of his resignation as President of CCBG and as Chairman of the Board of Capital City Bank, and Mr. Barron notified the Bank of resignation as President of the Bank, each effective as of July 1, 2025.
Role change
Thomas A. Barron
President of Capital City Bank
CCBG ·
CAPITAL CITY BANK GROUP INC
appointed Thomas A. Barron as the Chairman of the Board of Directors of the Bank, each effective as of July 1, 2025. 2. On May 28, 2025, the Board of Directors of CCBG appointed Mr. Barron as President of CCBG, effective as of July 1, 2025. In connection with these changes, on May 27, 2025, William G. Smith, Jr. notified CCBG of his resignation as President of CCBG and as Chairman of the Board of Capital City Bank, and Mr. Barron notified the Bank of resignation as President of the Bank, each effective as of July 1, 2025.
Appointed
Thomas A. Barron
President of Capital City Bank Group
CCBG ·
CAPITAL CITY BANK GROUP INC
appointed Mr. Barron as President of CCBG, effective as of July 1, 2025.
Appointed
John D. Duke
Director
HBIO ·
HARVARD BIOSCIENCE INC
On June 2, 2025, the Board appointed John D. Duke to serve as a member of the Board, June 2, 2025.
Departed
Thomas Loewald
Director
HBIO ·
HARVARD BIOSCIENCE INC
On May 30, 2025, Thomas Loewald informed the Company of his resignation from the board of directors (the “Board”) of Harvard Bioscience, Inc. (the “Company”), effective May 30, 2025.
Role change
Katherine Eade
Lead Independent Director
HBIO ·
HARVARD BIOSCIENCE INC
One June 2, 2025, the Board appointed Katherine Eade as the Board’s Lead Independent Director.
Departed
Kevin B. Reid, Sr.
General Counsel and Corporate Secretary
RGR ·
STURM RUGER & CO INC
Effective as of May 29, 2025, Kevin B. Reid, Sr. resigned as General Counsel and Corporate Secretary of the Company.
Appointed
Sarah F. Colbert
General Counsel and Corporate Secretary
RGR ·
STURM RUGER & CO INC
Sarah F. Colbert has been appointed to serve as General Counsel and Corporate Secretary of the Company, effective upon Mr. Reid’s resignation from such positions on May 29, 2025.
Departed
Najoh Tita-Reid
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
Andrew Obenshain
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
Mark Vachon
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
Richard Paulson
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
Joseph Vittiglio
Other Named Officer
bluebird bio, Inc.
the employment of each of Messrs. Andrew Obenshain, Joseph Vittiglio, and O. James Sterling (the “Executives”) has terminated as of the Effective Time.
Departed
Charlotte Jones-Burton
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
John O. Agwunobi
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
Nick Leschly
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
Andrew Obenshain
Other Named Officer
bluebird bio, Inc.
the employment of each of Messrs. Andrew Obenshain, Joseph Vittiglio, and O. James Sterling (the “Executives”) has terminated as of the Effective Time.
Departed
Mike Cloonan
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
Lis Leiderman
Director
bluebird bio, Inc.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
Departed
O. James Sterling
Other Named Officer
bluebird bio, Inc.
the employment of each of Messrs. Andrew Obenshain, Joseph Vittiglio, and O. James Sterling (the “Executives”) has terminated as of the Effective Time.
Departed
Robert Cochran
Director
Techpoint, Inc.
each of Fumihiro Kozato, Dr. Feng Kuo, Robert Cochran, Fun-Kai Liu, and Dr. Yaichi Aoshima ceased to serve on the board of directors
Role change
Michelle P. Ho
Chief Financial Officer
Techpoint, Inc.
Michelle P. Ho's title was changed from Interim Chief Financial Officer to Chief Financial Officer
Departed
Fumihiro Kozato
Principal Executive Officer and Director
Techpoint, Inc.
Fumihiro Kozato ceased to serve as the principal executive officer
Departed
Darron Ma
Principal Operating Officer
Techpoint, Inc.
Darron Ma ceased to serve as the principal operating officer
Appointed
Chewei Lin
President and Chairman
Techpoint, Inc.
Chewei Lin became the sole director of the Surviving Corporation and was appointed as the President and Chairman of the Surviving Corporation
Departed
Fun-Kai Liu
Director
Techpoint, Inc.
each of Fumihiro Kozato, Dr. Feng Kuo, Robert Cochran, Fun-Kai Liu, and Dr. Yaichi Aoshima ceased to serve on the board of directors
Departed
Dr. Yaichi Aoshima
Director
Techpoint, Inc.
each of Fumihiro Kozato, Dr. Feng Kuo, Robert Cochran, Fun-Kai Liu, and Dr. Yaichi Aoshima ceased to serve on the board of directors
Role change
Dr. Feng Kuo
Chief Executive Officer
Techpoint, Inc.
Dr. Feng Kuo was appointed as the Chief Executive Officer
Departed
Anthony M. Corriggio
President and Chief Operating Officer
Cohen & Steers Income Opportunities REIT, Inc.
On May 30, 2025, Anthony M. Corriggio provided notice to Cohen & Steers Income Opportunities REIT, Inc. (the “Company”) of his decision to retire from his positions as President and Chief Operating Officer of the Company, after a 33-year career in the real estate industry.
Appointed
Gregory K. Chow
Chief Financial Officer
STRO ·
SUTRO BIOPHARMA, INC.
On June 2, 2025 Sutro Biopharma, Inc. (the “Company”) announced the appointment of Gregory K. Chow as its Chief Financial Officer, principal financial officer and principal accounting officer, effective as of June 2, 2025.
Appointed
Sandra Alves
Senior Vice President, Chief Accounting Officer and principal accounting officer
Repare Therapeutics Inc.
In connection with Ms. Alves’ appointment as the Company’s Senior Vice President, Chief Accounting Officer and principal accounting officer, the Company entered into an employment agreement with Ms. Alves on May 28, 2025 (the “ Employment Agreement ”).
Role change
Robert S. Chambers
President
COLD ·
AMERICOLD REALTY TRUST
Robert S. Chambers, previously serving as President, Americas, will assume the newly created executive role of President
Appointed
M. Bryan Verbarendse
President, Americas
COLD ·
AMERICOLD REALTY TRUST
M. Bryan Verbarendse, previously serving as Executive Vice President and Chief Operating Officer, Americas, will succeed Mr. Chambers as President, Americas.
Role change
John Rettig
President and Chief Operating Officer
BILL ·
BILL Holdings, Inc.
John Rettig, the Company’s current President and Chief Financial Officer, will transition to serve as the Company’s President and Chief Operating Officer.
Appointed
Rohini Jain
Chief Financial Officer
BILL ·
BILL Holdings, Inc.
announcing the appointment of Rohini Jain as Chief Financial Officer of the Company, effective as of July 7, 2025
Appointed
John M. Engquist
Director
HRI ·
HERC HOLDINGS INC
On May 29, 2025, the Company expanded the size of its Board of Directors (the “Board”) from seven members to eight members and, under the terms of the Merger Agreement, appointed Mr. John M. Engquist (who previously served as a member on the H&E board of directors) to the Board.
Appointed
David Farren
Director
H&E Equipment Services, Inc.
In connection with the consummation of the Acquisition, at the Effective Time on June 2, 2025, David Farren, Jennifer Laudermilch, and Derek Lively became directors of the Company.
Departed
Brad Barber
Other Named Officer
H&E Equipment Services, Inc.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
Departed
Thomas J. Galligan III
Director
H&E Equipment Services, Inc.
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
Appointed
S. Wade Sheek
Secretary
H&E Equipment Services, Inc.
In connection with the consummation of the Acquisition, at the Effective Time, Lawrence H. Silber as President, David Farren as Vice President, S. Wade Sheek as Secretary, Jennifer Laudermilch as Treasurer, Derek Lively as Assistant Secretary and Christian Cunningham as Chief Human Resource Officer became executive officers of the Company.
Departed
John McDowell Engquist
Other Named Officer
H&E Equipment Services, Inc.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
Departed
Mary P. Thompson
Director
H&E Equipment Services, Inc.
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
Appointed
Derek Lively
Director
H&E Equipment Services, Inc.
In connection with the consummation of the Acquisition, at the Effective Time on June 2, 2025, David Farren, Jennifer Laudermilch, and Derek Lively became directors of the Company.
Departed
John M. Engquist
Director
H&E Equipment Services, Inc.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
Departed
Leslie S. Magee
Other Named Officer
H&E Equipment Services, Inc.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
Appointed
Christian Cunningham
Chief Human Resource Officer
H&E Equipment Services, Inc.
In connection with the consummation of the Acquisition, at the Effective Time, Lawrence H. Silber as President, David Farren as Vice President, S. Wade Sheek as Secretary, Jennifer Laudermilch as Treasurer, Derek Lively as Assistant Secretary and Christian Cunningham as Chief Human Resource Officer became executive officers of the Company.
Departed
Lawrence C. Karlson
Director
H&E Equipment Services, Inc.
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
Appointed
Jennifer Laudermilch
Treasurer
H&E Equipment Services, Inc.
In connection with the consummation of the Acquisition, at the Effective Time, Lawrence H. Silber as President, David Farren as Vice President, S. Wade Sheek as Secretary, Jennifer Laudermilch as Treasurer, Derek Lively as Assistant Secretary and Christian Cunningham as Chief Human Resource Officer became executive officers of the Company.
Appointed
Jennifer Laudermilch
Director
H&E Equipment Services, Inc.
In connection with the consummation of the Acquisition, at the Effective Time on June 2, 2025, David Farren, Jennifer Laudermilch, and Derek Lively became directors of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.